Pfizer Dermatology Patient Access Interim Care Rx Program: Cibinqo
Funded
About
The Pfizer Dermatology Patient Access Interim Care Rx Program: Cibinqo offers eligible patients access to the drug Cibinqo at no cost for up to 2 years, ensuring continued treatment despite insurance delays or denials. This program is a significant benefit for those with commercial insurance and an FDA-approved diagnosis, providing vital support for managing dermatological conditions.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Eligible commercially insured patients may receive up to 2 years of medication at no cost shipped to the patient's home if there is an insurance delay or denial
•Continued eligibility for the program requires submission of two appeals within 180 days of enrollment
•After 12 months of program enrollment, an updated prescription and benefits investigation is required to confirm continued eligibility
•Not available to residents in the states of Massachusetts, Michigan, Minnesota, Missouri, Ohio, or Rhode Island
•Call 8444968707, MondayFriday, 8:00 am to 8:00 pm ET with any questions
Enrollment Forms
Enrollment Form